Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01316250
Title Gleevec as Maintenance Therapy After Cytogenetic Response With Nilotinib in Newly Diagnosed Chronic Myelogenous Leukemia
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors American University of Beirut Medical Center
Indications
Therapies
Age Groups: senior | adult
Covered Countries LBN


No variant requirements are available.